NEW YORK, NY / ACCESSWIRE / June 28, 2017 / The Klein Law Firm announces that securities complaint has been filed on behalf of shareholders of Avinger, Inc. (NASDAQ: AVGR) who purchased shares pursuant and/or traceable to the Company’s Stock Offering on or about January 30, 2015.

The complaint alleges that the Registration Statement and Prospectus filed for the Company’s Initial Public Offering contained materially false and misleading statements and/or failed to disclose that: (1) Avinger did not have adequate sales and marketing personnel to increase sales of its lumivascular platform products and to commercialize Pantheris; (2) the Company already experienced problems with the robustness of its lumivascular platform devices, including Pantheris; (3) physicians and hospitals were requiring more extensive and comprehensive training and education on the benefits of Avinger’s products to convince them to adopt and implement its lumivascular platform products compared to competing products and procedures available in the market; (4) Avinger would not be able to achieve a rapid ramp rate for increased sales of its lumivascular platform; and (5) as a result, the Company was experiencing lower sales and revenues.

If you suffered a loss in Avinger and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit http://www.kleinstocklaw.com/pslra-sa/avinger-inc?wire=1.

Joseph Klein, Esq. is an experienced attorney and has also practiced as a Certified Public Accountant. Mr. Klein represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 467071

NEW YORK, NY / ACCESSWIRE / June 28, 2017 / The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of SunPower Corporation (“SunPower”) (NASDAQ: SPWR) between February 17, 2016 and August 9, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of California. To get more information go to: http://www.zlk.com/pslra-sb/sunpower-corporation-2?wire=1 or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) a substantial number of SunPower’s customers were adopting a longer-term timeline for project completion; (2) SunPower’s near-term economic returns were deteriorating due to aggressive PPA pricing by new market entrants; (3) market disruption in the YieldCo environment was impacting SunPower’s assumptions related to monetizing deferred profits; (4) as a result, demand for the Company’s products was significantly decreasing; (5) in response, SunPower would implement a manufacturing realignment that would result in significant restructuring charges; and (6) consequently, the Company’s fiscal year 2016 guidance was overstated.

If you suffered a loss in SunPower you have
until July 21, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 467070

IRVINE, CA / ACCESSWIRE / June 28, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against SunPower Corporation (“SunPower” or the “Company”) (NASDAQ: SPWR). Investors who purchased or otherwise acquired shares from February 17, 2016 through August 9, 2016, inclusive (the “Class Period”), are encouraged to contact the Firm before the July 21, 2017 lead plaintiff motion deadline.

If you purchased SunPower shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

According to the Complaint, during the Class Period, SunPower made materially false and/or misleading statements and/or failed to disclose: that a significant number of its customers were adopting a longer-term timeline for project completion; that SunPower’s near-term economic returns were deteriorating due to aggressive PPA pricing by new market entrants; that market disruption in the YieldCo environment was affecting the Company’s assumptions related to monetizing deferred profits; that as a result, demand for SunPower products was significantly declining; that the Company implemented a manufacturing realignment that would result in significant restructuring charges; that the Company’s fiscal year 2016 guidance was overstated; and that as a result of the above, SunPower’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When this information was released, shares of SunPower fell in value materially, which harmed investors according to the Complaint.

If you wish to learn more about this lawsuit, or if you have any questions regarding this notice or your rights, please contact Joon M. Khang, a prominent litigator for nearly two decades, by telephone: (949) 419-3834, or via e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in certain jurisdictions.

Contact

Joon M. Khang, Esq.

Telephone: 949-419-3834

Facsimile: 949-225-4474

joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467069

IRVINE, CA / ACCESSWIRE / June 28, 2017 / Khang & Khang LLP (the “Firm”) announces a securities class action lawsuit against Eco Science Solutions, Inc. (“Eco Science” or the “Company”) (OTC PINK: ESSI). Investors, who purchased or otherwise acquired shares between May 1, 2017 and May 19, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm before the July 24, 2017 lead plaintiff motion deadline.

If you purchased Eco Science shares during the Class Period, please contact Joon M. Khang, Esq., of Khang & Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone at (949) 419-3834, or via e-mail at joon@khanglaw.com.

There has been no class certification in this case yet. Until certification occurs, you are not represented by an attorney. You may also choose to take no action and remain a passive class member.

According to the Complaint, throughout the Class Period, Eco Science made materially false and misleading statements, and/or failed to disclose, that its plan for strategic acquisitions lacked veracity. On May 19, 2017, the U.S. Securities and Exchange Commission announced a temporary suspension of the trading of the Company’s securities “because of concerns regarding the accuracy and adequacy of publicly disseminated information concerning, among other things, ESSI’s proposed acquisition of Ga-Du Bank, Inc.”

If you wish to learn more about this lawsuit, or if you have any questions about this notice or your rights, please contact Joon M. Khang, Esq., a prominent litigator for nearly two decades, by telephone at (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may be considered Attorney Advertising in certain jurisdictions.

Contact:

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 467068

CINCINNATI, OH / ACCESSWIRE / June 28, 2017 / M Pharmaceutical Inc. (CNSX: MQ, OTCQB: MPHMF, FRA: T3F2) (the “Company” or “M Pharma”) announced today that it has, in respect to 57,838,619 warrants exercisable at $0,05 per share expiring on June 27 and June 30, 2017, extended the expiry date on these warrants to August 15, 2017.

Proceeds from the exercise of these warrants will be used for working capital and for marketing of the Company’s ToConceive product launch, scheduled for July, 2017.

About M Pharmaceutical Inc.

Formed in early 2015, M Pharmaceutical Inc. is a clinical-stage company developing innovative technologies for obesity, weight management, and female health and wellness. In addition to its recent acquisitions of C-103, a reformulation of orlistat, and assets from 40J’s LLC, the Company is scheduled to launch their FDA cleared fertility product branded as ToConceive in July of this year.

M Pharma trades on the Canadian Securities Exchange (CSE) under the ticker symbol “MQ,” as well as on the OTCQB as “MPHMF,” and FWB (Frankfurt Stock Exchange) as “T3F2.”

For more information, contact:

Investor Relations
Phone: +1 604 428 0511
info@m-pharma.ca
www.m-pharma.ca

Notice Regarding Forward-Looking Statements:

This news release contains forward-looking statements. The use of any of the words “anticipate,” “continue,” “estimate,” “expect,” “may,” “will,” “project,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the regulatory approval, commercialization of the rights to the Company’s biomedical & drug technologies, and acquisition of new products. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com and the Company’s filings to the CSE at www.cnsx.ca. Such risk factors may cause the inability of the Company to successfully commercialize any of its biomedical technologies.

Notice Regarding Investigational Devices

C-103 and Trimeo are investigational drugs or devices and are not currently available outside of approved clinical trials. Claims regarding the safety and efficacy of these devices have not been evaluated by Health Canada, the U.S. Food and Drug Administration, or any other international regulatory body.

SOURCE: M Pharmaceutical Inc.

ReleaseID: 467056

LOS ANGELES, CA / ACCESSWIRE / June 28, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Dick’s Sporting Goods, Inc. (“Dick’s” or the “Company”) (NYSE: DKS) regarding possible violations of federal securities laws from March 7, 2017 through May 15, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the July
17, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Dick’s made false and/or misleading statements and/or failed to disclose: that the Company overstated its adjusted EBITDA amounts; that Dick’s lacked effective internal controls; and that as a result of the above, the Company’s public statements were materially false and misleading at all relevant times. On May 12, 2017, Dick’s issued a Current Report filed on Form 8-K/A with the SEC, reporting that a “computation error resulted in a $23.4 million overstatement of Adjusted EBITDA amounts for both the 13 weeks and 52 weeks ended January 28, 2017.” Upon release of this news, Dick’s share price fell $2.62, or 5.22%, over the next two trading days. On May 16, 2017, Dick’s announced that sales at its existing stores in the first quarter of 2016 fell short of forecasts and advised investors that the Company planned to scale back new store openings in 2018 and 2019. After the release of this news, Dick’s stock price dropped materially, which caused invesotrs harm according to the Complaint.

Lundin Law PC was established by Brian Lundin, a securities litigator based in Los Angeles devoted to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and rules of ethics.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 467065

LOS ANGELES, CA / ACCESSWIRE / June 28, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Signet Jewelers Limited (“Signet” or the “Company”) (NYSE: SIG) regarding violations of federal securities laws from August 29, 2013 through February 27, 2017, inclusive (the “Class Period”). Investors, who purchased or otherwise acquired Signet shares during the Class Period, should contact the firm prior to new July 5, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Signet issued false and misleading statements and/or failed to disclose that alleged sexual harassment by employees of Signet’s Sterling Family of Jewelers division (“Sterling”), including numerous incidents of sexual assault and rape which were detailed in approximately 249 declarations signed under penalty of perjury by current and former Sterling employees, made it unlikely that Signet would be able to avoid paying a sizable amount of damages in connection with a class action lawsuit filed by Sterling employees. Signet’s stock traded at artificially inflated prices during the Class Period as a result of this information being withheld from the market. On February 27, 2017, The Washington Post reported on widespread allegations of sexual harassment made in the private arbitration that implicated the Company’s senior managers and executives. When this information was revealed to the public, Signet’s share price fell materially, which harmed investors according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may constitute Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 467066

LOS ANGELES, CA / ACCESSWIRE / June 28, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Barrick Gold Corporation (“Barrick” or the “Company”) (NYSE: ABX) for possible violations of federal securities laws from February 16, 2017 through April 24, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired Barrick shares during the Class Period should contact the firm prior to the July 10, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may do nothing and be an absent class member as well.

According to the Complaint, throughout the Class Period, Barrick made materially false and/or misleading statements, and failed to disclose: that the pipes and safety systems at its Veladero mine were not robust enough to prevent gold-bearing solution spills; that Argentinian authorities would restrict the addition of cyanide to the Veladero mine’s heap leach facility and require remedial work; that these developments would impact the production capacity of the Veladero mine; that Barrick’s Veladero mine production guidance and total gold production guidance were overstated; and that as a result of the above, the Company’s statements about its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis at all relevant times.

On April 24, 2017, Barrick revised its full year guidance, stating that “[f]ull-year gold production is now expected to be 5.3-5.6 million ounces, down from our previous range of 5.6-5.9 million ounces.” The Company attributed about two-thirds of the decrease to the planned sale of 50% percent of its Veladero mine. Barrick also revised Veladero-specific guidance, forecasting full-year production at Veladero of 630,000-730,000 ounces, compared to its previously-issued guidance of 770,000-830,000 ounces. When this news was announced, Barrick’s stock price dropped materially, which harmed investors according to the Complaint.

Lundin Law PC was established by Brian Lundin, Esq., a securities litigator based in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 467063

LOS ANGELES, CA / ACCESSWIRE / June 28, 2017 / Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Asanko Gold Inc. (“Asanko” or the “Company”) (NYSE MKT: AKG) for possible violations of federal securities laws from October 24, 2014 through May 31, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired shares during the Class Period should contact the firm prior to the July
31, 2017 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here.

You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the Complaint, throughout the Class Period, Asanko made false and/or misleading statements, and/or failed to disclose that: Asanko’s Mineral Resource Estimates are flawed; that some of the Company’s resources models show signs that they have been “smeared,” which would cause estimates of their ore contents to be inflated; and that as a result of the above, Asanko’s public statements were materially false and misleading at all relevant times. On May 31, 2017, research firm Muddy Waters published a report asserting, among other things, that: Asanko made investments based on flawed geology in Nkran, its satellite pits, and Esaase that Muddy Waters believes “will never be recovered;” and that there are indicia that some of the Company’s resources models have been “smeared,” which would cause estimates of their ore contents to be inflated. Upon the release of this news, Asanko shares decreased in value, which caused investors harm according to the Complaint.

Lundin Law PC was founded by Brian Lundin, Esq., a securities litigator located in Los Angeles dedicated to upholding the rights of shareholders.

This press release may be considered Attorney Advertising in certain jurisdictions under the applicable law and ethics rules.

Contact:

Lundin Law PC

Brian Lundin, Esq.

Telephone: 888-713-1033

Facsimile: 888-713-1125

brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC

ReleaseID: 467064